Preparation And Storage
Recommended Assay Procedures
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes (including BD OptiBuild Brilliant reagents) are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794).
Product Notices
- This antibody was developed for use in flow cytometry.
- The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
- Researchers should determine the optimal concentration of this reagent for their individual applications.
- An isotype control should be used at the same concentration as the antibody of interest.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- BD Horizon Brilliant Stain Buffer is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,575,303; 8,354,239.
- BD Horizon Brilliant Violet 786 is covered by one or more of the following US patents: 8,110,673; 8,158,444; 8,227,187; 8,455,613; 8,575,303; 8,354,239.
- Cy is a trademark of GE Healthcare.
Companion Products
The 174031 monoclonal antibody specifically recognizes CD354 which is also known as Triggering receptor expressed on myeloid cells 1 (TREM-1) or Triggering receptor expressed on monocytes 1. CD354 (TREM-1) is a ~30 kDa single-pass type I transmembrane glycoprotein that is encoded by Trem1 which belongs to the V-set domain containing family within the Ig superfamily. CD354 (TREM-1) can associate with DAP12, an adaptor protein that contains an immunoreceptor tyrosine-based activation motif (ITAM), to deliver an activating signal intracellularly. It is expressed on neutrophils and some monocytes and macrophages with upregulated expression triggered in response to bacterial lipopolysaccharide (LPS) exposure. CD354 (TREM-1) appears to play important roles in inflammation and septic shock by inducing the production of pro-inflammatory cytokines and chemokines including TNF and MCP-1/CCL2. A soluble form of TREM-1 may be released by cells and serve as an inhibitor of cell surface TREM-1 function.
The antibody was conjugated to BD Horizon™ BV786 which is part of the BD Horizon Brilliant™ Violet family of dyes. This dye is a tandem fluorochrome of BD Horizon BV421 with an Ex Max of 405-nm and an acceptor dye with an Em Max at 786-nm. BD Horizon BV786 can be excited by the violet laser and detected in a filter used to detect Cy™7-like dyes (eg, 780/60-nm filter).
Development References (3)
-
Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000; 164(10):4991-4995. (Biology). View Reference
-
Gibot S, Massin F, Marcou M, et al. TREM-1 promotes survival during septic shock in mice.. Eur J Immunol. 2007; 37(2):456-66. (Clone-specific: Flow cytometry). View Reference
-
Yuan Z, Syed MA, Panchal D, et al. Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival.. J Biol Chem. 2014; 289(21):15118-29. (Clone-specific: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
